SS
CELG

Steve Schonfeld’s Celgene Corp CELG Stock Holding History

Steve Schonfeld’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-455,486
Closed -$45.2M – 1584
2019
Q3 		$45.2M Buy
455,486
+430,853
+1,749% +$40.9M 1.33% 6
2019
Q2 		$2.28M Buy
24,633
+5,433
+28% +$516K 0.08% 267
2019
Q1 		$1.81M Sell
19,200
-163,900
-90% -$14.3M 0.06% 365
2018
Q4 		$11.7M Buy
183,100
+165,700
+952% +$12.2M 0.45% 44
2018
Q3 		$1.56M Sell
17,400
-66,240
-79% -$5.85M 0.07% 337
2018
Q2 		$6.64M Buy
+83,640
New +$6.94M 0.36% 77
2017
Q3 		– Sell
-2,499
Closed -$325K – 882
2017
Q2 		$325K Buy
+2,499
New +$306K 0.03% 460
2017
Q1 		– Sell
-20,000
Closed -$2.31M – 835
2016
Q4 		$2.31M Sell
20,000
-341
-2% -$38K 0.3% 95
2016
Q3 		$2.13M Buy
20,341
+144
+0.7% +$15.6K 0.36% 69
2016
Q2 		$1.99M Sell
20,197
-5,116
-20% -$529K 0.45% 51
2016
Q1 		$2.53M Buy
+25,313
New +$2.61M 1.03% 17

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $341K AUM 32.64% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Steve Schonfeld's CELG Position: Q4 2019 in Review

Steve Schonfeld sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 455,486 shares — an estimated $45.2M sold.

Steve Schonfeld first reported a position in CELG in Q1 2016 and held it in 11 quarters. The position peaked at $45.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Steve Schonfeld reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Steve Schonfeld sold 455,486 Celgene Corp shares in Q4 2019, an estimated $45.2M.
  • Steve Schonfeld first reported a position in Celgene Corp in Q1 2016 and held it in 11 quarters.
  • Steve Schonfeld's Celgene Corp position peaked at $45.2M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.